In a cross-sectional study of 240 patients with chronic kidney disease, higher serum BDNF levels and a ...

Medical experts in Bengaluru are seeing a significant rise in pre-emptive kidney transplants, allowing patients to bypass dialysis. Doctors highlight improved long-term health outcomes and reduced ...

Alexion, AstraZeneca Rare Disease’s Ultomiris (ravulizumab) has been approved in the United States to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of disease ...

The US FDA has approved GSK’s Hibsago for chronic hepatitis B, with 19% of trial participants achieving a functional cure.

A computational study identified 368 putative compounds in Guduchyadi Yoga and modeled persistent binding by three selected phytochemicals to AKT1, PPARG and TNF, but did not test therapeutic effects ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Commission (EC) has approved KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination ...

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a clinical trial collaboration with the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) to evaluate ivonescimab, a novel, potential first-in-class ...

Alexion, AstraZeneca Rare Disease's Ultomiris (ravulizumab) has been approved in the US to reduce proteinuria in adults with primary immunoglobulin A ...

Alexion, AstraZeneca Rare Disease's Ultomiris (ravulizumab) has been approved in the US to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression ...

Scopri come l'alcol altera i delicati equilibri renali. Dai falsi miti sulla disidratazione ai veri segnali d'allarme per ...